BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTMSS - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CTMSS
X-ORIGINAL-URL:https://clinicaltmssociety.org
X-WR-CALDESC:Events for CTMSS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210921
DTEND;VALUE=DATE:20210922
DTSTAMP:20260613T133709
CREATED:20241107T204331Z
LAST-MODIFIED:20241108T134502Z
UID:1521-1632182400-1632268799@clinicaltmssociety.org
SUMMARY:September 2021 New Member Welcome Meeting
DESCRIPTION:September 21\, 2021 New Member Welcome Meeting  \nYou’re invited to join the Clinical TMS Society for the September 21\, 2021 New Member Welcome Meeting.  \nPresentation Overview:  \nIntroductory Orientation Meeting for New Members of the Clinical TMS Society \nThe Membership Committee of the CTMSS has initiated a new program of bimonthly virtual orientation meetings to assist new members in how to most effectively engage with our Society and to obtain the most benefit from their CTMSS membership. The meeting will be led by our President Randy Pardell\, MD\, DLFAPA\, and Membership Committee Co-chair Rebecca Cohen\, MD. \nObjectives:  \n\nLearn the history of CTMSS and its mission statement\, bylaws\, committee structure and administration.\nLearn the different levels of membership and how to maximize your membership experience.\nLearn educational opportunities within CTMSS programs.\nUnderstand our website and how to navigate its rich content.\nLearn how to keep up to date with the ever changing landscape of TMS therapy and the burgeoning activities of our society through our website and society activities.\n\nDate: September 21\, 2021 \nTime: 5:00 pm PDT\, 8:00 pm EDT \nFormat: LIVE \nThis meeting is for current members only. \n\nSPEAKERS:  \nRebecca Cohen\, MD\, Membership Committee Co-chair\nDr. Cohen has been an active member of the Clinical TMS Society and now serves as the Co-Chair of the Membership Committee and begins her tenure on the National Board in June 2021. \nDr. Cohen earned her Bachelor of Science in Biopsychology at Tufts University in Medford\, Mass.\, and her Master of Medical Science at Boston University’s Graduate School of Arts & Sciences based on research completed at Harvard Medical School. Dr. Cohen completed her medical degree at Boston University School of Medicine where she was recipient of the psychiatry department’s Malamud Award for Excellence. She completed her Psychiatry Residency training at Georgetown University Medical Center in Washington\, D.C.\, where she served as Chief Psychiatry Resident at Georgetown Hospital during her final year. \nFrom 2001 to 2012\, Dr Cohen joined the staff at Newton Wellesley Psychiatry in Massachusetts\, specializing in adult psychiatry and psychopharmacology. She pioneered one of the first private practice TMS Programs in MA in 2010 and was the site contributor to the TMS National Outcome Study.  After relocating to Sarasota\, Florida in 2012\, she became TMS director in a private practice and then in 2018 joined Greenbrook TMS Neurohealth Centers where she serves as Central Florida Regional Medical Director\, providing direct clinical care and patient advocacy in her role.  \nIn addition to her TMS work\, Dr. Cohen owns and manages her private practice providing concierge level of care throughout Central Florida.  She has excelled in her role as Clinical Assistant Professor for psychiatry clerkship instructing students at Florida State University School of Medicine.  Dr Cohen has been recognized for excellence in teaching and clinical practice throughout her career. Most recently\, Dr. Cohen has been honored as a Doctor of Distinction by Sarasota Scene Magazine in 2018 and 2020\, recognized as a Top Doctor by Sarasota Magazine and was inducted into Marquis Who’s Who in June 2020.  \nRandy Pardell\, MD\, DLFAPA\, CTMSS President\nDr. Pardell is currently the President of the Clinical TMS Society.  He has served on the Board of Directors of CTMSS for the past 4 years and has been elected to the Executive Committee as Member at Large for two terms and now as Vice President. He has been past Chairman of the Outreach Committee and has served on the Membership and Education Committees. He has been a returning lecturer for the CTMSS Pulses Course.   He has been practicing TMS therapy since 2009. He co-wrote the first lay book on TMS called 3000 Pulses. Dr. Pardell is an honors graduate of the University of Pennsylvania and New York University School of Medicine. He completed his residency and chief residency at the St. Luke’s Roosevelt Medical Center and Post-Doctoral Fellowship at Columbia University where he performed smoking cessation research with Alexander Glassman MD. After graduation from his psychiatric training\, Dr. Pardell moved up with his wife to the beautiful Hudson Valley\, New York to start a practice and raise a family. Dr. Pardell is a Distinguished Life Fellow of the American Psychiatric Association and has been a past President of the Mid-Hudson Psychiatric Society and had been its Program Director for over a decade. Dr. Pardell founded Riverview Psychiatric Medicine\, PC and TMS Center of the Hudson Valley and leads an active group psychiatric and TMS practice. 
URL:https://clinicaltmssociety.org/event/september-2021-new-member-welcome-meeting/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/2021_May_NMWM_Thumbnail_v2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210715
DTEND;VALUE=DATE:20210716
DTSTAMP:20260613T133709
CREATED:20241107T204203Z
LAST-MODIFIED:20250312T184309Z
UID:1518-1626307200-1626393599@clinicaltmssociety.org
SUMMARY:2021 Poster Session: A Virtual Experience
DESCRIPTION:We are excited to announce that the 2021 posters will be available for online viewing through December 31\, 2021. As the window to view the posters are limited\, we encourage everyone to register asap\, to receive the max allotted time.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWe have a total of 29 authors/presenters sharing their critical insights and research findings. \nEarn up to a max of 7.25 hours of CME depending on how many posters you choose to view. \nInstructions on how to access the posters and obtain CME will be included in your confirmation email. \nCosts: \n\nCTMSS Members: $25 USD\nNon-Members: $85 USD\n\nAll registrations will be checked for membership. \n\nAcknowledgment of Financial Commercial Support\nNo financial commercial support was received for this educational activity. \nAcknowledgment of In-Kind Commercial Support\nNo in-kind commercial support was received for this educational activity. \nSatisfactory Completion\nLearners must review each poster chosen and take up to 15 minutes to absorb the information and complete an evaluation form to receive a certificate of completion. \nComplete all posters you wish to view before completing the evaluation. \nIf you are seeking continuing education credit for a specialty not listed below\, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. \n\n\nPhysicians \n \nIn support of improving patient care\, this activity has been planned and implemented by Amedco LLC and Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, to provide continuing education for the healthcare team. \nCredit Designation Statement – Amedco LLC designates this enduring material for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nObjectives - After Attending This Program You Should Be Able To \n\nIdentify evidence for various TMS treatment approaches compared to standard TMS approach\nDiscuss the effectiveness of TMS in various populations and settings\nDiscuss predictive biomarkers and/or clinical markers of response to repetitive transcranial magnetic stimulation (rTMS) treatment\n\nDisclosure of Conflict of Interest \nThe following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest\, and have been resolved. (C7 SCS 6.1-­‐6.2\, 6.5) \nAll individuals in a position to control the content of CE are listed on the website. If their name is not listed below\, they disclosed that they had no financial relationships with a commercial interest. \n\n\n\nFirst Name\nLast Name\nCommercial Interest: Relationship\n\n\n\n\nScott\nAaronson\nNeuronetics:Research Grant Site Principal Investigator\,Janssen:Consultant\,Sage Therapeutics:Consultant\,Compass Pathways:Research Grant Site Principal Investigator\,Genomind:Scientific/Medical Advisory Board Member\,LivaNova:Consultant\,Neurolief:Consultant\,Neuronetics:Consultant\,Compass Pathways:Research Grant Overall Principal Investigator\n\n\nPaul\nCroarkin\nNeuronetics\, Inc:Research Grant Site Principal Investigator\,Pfizer\, Inc:Research Grant Overall Principal Investigator\,Assurerx Health:Other\,Procter & Gamble Company:Consultant\,Sunovian :Scientific/Medical Advisory Board Member\,NeoSync:Research Grant Site Principal Investigator\,MagVenture: Equipment Support \,Myriad Neuroscience:Consultant\,Engrail Therapeutics:Scientific/Medical Advisory Board Member\,Neuronetics:Equipment Support\n\n\nNancy\nDonachie\nSmart Health & Wellness Centers:Stock Shareholder\,Salience TMS Neuro Solutions:Scientific/Medical Advisory Board Member\,Smart Health & Wellness Centers:Scientific/Medical Advisory Board Member\n\n\nDavid\nDunner\nNeuronetics:Other Financial or Material Support/consultant\,Cyberonics/Livanova:Other Financial or Material Support/Research support\,Janssen:Consultant\n\n\nTodd\nHutton\nNeuronetics:Consultant\,Southern California TMS Center:Stock Shareholder\n\n\nJoseph\nKriske\nSalience TMS Neuro Solutions:Stock Shareholder\n\n\nAdonis\nMaiquez\nCommercial interest:Own BrainsWay TMS machine\n\n\nLucian\nManu\nResearch Funding:Research Grant Site Principal Investigator\n\n\nLeigh\nNeal\nSmart TMS:Medical Director of Smart TMS\n\n\nLeigh\nNeal\nSmart TMS:Medical Director of Smart TMS\n\n\nRandy\nPardell\nNeuronetics :Co-marketing\n\n\nRandy\nPardell\nNeuronetics :Co-marketing\n\n\nKenny\nPerez\nSuccessTMS:Consultant\n\n\nYiftach\nRoth\nBrainsWay Ltd.:Stock Shareholder\n\n\nDebra\nStultz\nJazz Pharmaceticuls:Speakers Bureau\,Harmony Biosciences:Speakers Bureau\n\n\nARON\nTENDLER\nBrainsway:Consultant\,Brainsway:Stock Shareholder\n\n\n\n\n\n\n\n\nWhen\nJuly 15th\, 2021 8:00 AM to July 17th\, 2021 11:59 PM\n\n\n\nContact\n\nPhone: 8453923238\nEmail: info@clinicaltmssociety.org\nEmail: info@clinicaltmssociety.org\n\n\n\n\nVirtual Poster Session Costs\n\n\n\n\nVirtual Poster Session Costs\n\n\n\nCTMSS Member\n$25.00\n\n\nNon-Member\n$85.00\n\n\nComplimentary Registration\n\n\n\nRegistered for Annual Meeting\n$0.00\n\n\nRegistered for Live Stream\n$0.00\n\n\n\n\n\n\n\n\n\n\n\n\n 
URL:https://clinicaltmssociety.org/event/2021-poster-session-a-virtual-experience/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/png:https://clinicaltmssociety.org/wp-content/uploads/2024/11/Clinical-TMS-Feature-Image-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210519
DTSTAMP:20260613T133709
CREATED:20241107T203928Z
LAST-MODIFIED:20250312T183304Z
UID:1516-1621296000-1621382399@clinicaltmssociety.org
SUMMARY:May 18\, 2021 New Member Welcome Meeting 
DESCRIPTION:May 18\, 2021 New Member Welcome Meeting  \nYou’re invited to join the Clinical TMS Society for the May 18\, 2021 New Member Welcome Meeting.  \nPresentation Overview:  \nIntroductory Orientation Meeting for New Members of the Clinical TMS Society \nThe Membership Committee of the CTMSS has initiated a new program of bimonthly virtual orientation meetings to assist new members in how to most effectively engage with our Society and to obtain the most benefit from their CTMSS membership. The meeting will be led by our Vice President/President-Elect Randy Pardell\, MD\, DLFAPA\, and Membership Committee Co-chair Rebecca Cohen\, MD. \nObjectives:  \n\nLearn the history of CTMSS and its mission statement\, bylaws\, committee structure and administration.\nLearn the different levels of membership and how to maximize your membership experience.\nLearn educational opportunities within CTMSS programs.\nUnderstand our website and how to navigate its rich content.\nLearn how to keep up to date with the ever changing landscape of TMS therapy and the burgeoning activities of our society through our website and society activities.\n\nDate: May 18\, 2021 \nFormat: ON-DEMAND \nThis meeting is for current members only. \n\nSPEAKERS:  \nRebecca Cohen\, MD\, Membership Committee Co-chair\nDr. Cohen has been an active member of the Clinical TMS Society and now serves as the Co-Chair of the Membership Committee and begins her tenure on the National Board in June 2021. \nDr. Cohen earned her Bachelor of Science in Biopsychology at Tufts University in Medford\, Mass.\, and her Master of Medical Science at Boston University’s Graduate School of Arts & Sciences based on research completed at Harvard Medical School. Dr. Cohen completed her medical degree at Boston University School of Medicine where she was recipient of the psychiatry department’s Malamud Award for Excellence. She completed her Psychiatry Residency training at Georgetown University Medical Center in Washington\, D.C.\, where she served as Chief Psychiatry Resident at Georgetown Hospital during her final year. \nFrom 2001 to 2012\, Dr Cohen joined the staff at Newton Wellesley Psychiatry in Massachusetts\, specializing in adult psychiatry and psychopharmacology. She pioneered one of the first private practice TMS Programs in MA in 2010 and was the site contributor to the TMS National Outcome Study.  After relocating to Sarasota\, Florida in 2012\, she became TMS director in a private practice and then in 2018 joined Greenbrook TMS Neurohealth Centers where she serves as Central Florida Regional Medical Director\, providing direct clinical care and patient advocacy in her role.  \nIn addition to her TMS work\, Dr. Cohen owns and manages her private practice providing concierge level of care throughout Central Florida.  She has excelled in her role as Clinical Assistant Professor for psychiatry clerkship instructing students at Florida State University School of Medicine.  Dr Cohen has been recognized for excellence in teaching and clinical practice throughout her career. Most recently\, Dr. Cohen has been honored as a Doctor of Distinction by Sarasota Scene Magazine in 2018 and 2020\, recognized as a Top Doctor by Sarasota Magazine and was inducted into Marquis Who’s Who in June 2020.  \nRandy Pardell\, MD\, DLFAPA\, CTMSS President-Elect\nDr. Pardell is currently the Vice President/President-elect of the Clinical TMS Society.  He has served on the Board of Directors of CTMSS for the past 4 years and has been elected to the Executive Committee as Member at Large for two terms and now as Vice President. He has been past Chairman of the Outreach Committee and has served on the Membership and Education Committees. He has been a returning lecturer for the CTMSS Pulses Course.   He has been practicing TMS therapy since 2009. He co-wrote the first lay book on TMS called 3000 Pulses. Dr. Pardell is an honors graduate of the University of Pennsylvania and New York University School of Medicine. He completed his residency and chief residency at the St. Luke’s Roosevelt Medical Center and Post-Doctoral Fellowship at Columbia University where he performed smoking cessation research with Alexander Glassman MD. After graduation from his psychiatric training\, Dr. Pardell moved up with his wife to the beautiful Hudson Valley\, New York to start a practice and raise a family. Dr. Pardell is a Distinguished Life Fellow of the American Psychiatric Association and has been a past President of the Mid-Hudson Psychiatric Society and had been its Program Director for over a decade. Dr. Pardell founded Riverview Psychiatric Medicine\, PC and TMS Center of the Hudson Valley and leads an active group psychiatric and TMS practice.  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhen\nMay 18th\, 2021 from  5:00 PM to  6:00 PM
URL:https://clinicaltmssociety.org/event/may-18-2021-new-member-welcome-meeting/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/Grand-Rounds.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210317
DTEND;VALUE=DATE:20210318
DTSTAMP:20260613T133709
CREATED:20241107T195618Z
LAST-MODIFIED:20241108T134524Z
UID:1506-1615939200-1616025599@clinicaltmssociety.org
SUMMARY:How to Best Utilize the New CTMSS Recommended OCD Coverage Policy
DESCRIPTION:>>WATCH NOW<<\nPresentation Overview:  \nThe webinar will review the key elements contained in the recommended coverage policy for Transcranial Magnetic Stimulation for the treatment of patients with treatment-resistant obsessive-compulsive disorder. Indication for coverage\, patient selection criteria including limitations\, and utilization guidelines and recommended TMS protocol will also be reviewed. At the end of the webinar\, providers will have a better understanding of how to utilize the coverage policy to advocate for their OCD patients. \nLearning Objectives: \n\nUnderstand the content in the policy;\nUnderstand the recommended patient selection criteria;\nUnderstand the clinical evidence to support the policy;\nUnderstand how to use the policy as a part of your initial payer coverage requests\, calls and/or meetings with medical directors and peer to peer conversations and appeals.\n\nDate: March 17\, 2021 \nTime: 5:00 pm PDT / 8:00 pm EDT \nFormat: ON-DEMAND \n*This event is FREE for CTMSS Members Only.  \n\nSPEAKERS:  \nCarlene MacMillan\, MD \nCarlene MacMillan\, MD is the co-Founder and CEO of Brooklyn Minds Psychiatry\, a multidisciplinary team-based multi-site practice in the NYC Region. She is a graduate of Harvard College and Harvard Medical School and completed her adult psychiatry residency and child and adolescent fellowship at Massachusetts General Hospital/McLean Hospital.  In her work at Brooklyn Minds\, she has built a robust deep TMS program over the past 4 years. Brooklyn Minds was one of the first practices in the country to offer deep TMS for OCD upon FDA clearance. As a member of the CTMSS Insurance Committee\, she focuses primarily on advocating for appropriate OCD coverage policies as her team at Brooklyn Minds has been at the forefront of obtaining insurance coverage from commercial and Medicaid payers. She is a co-author on the post-marketing paper on dTMS for OCD published earlier this year.   \nScott Blackman\, CMBS \nScott Blackman has 30 years of medical device and pharmaceutical industry experience working in the areas of sales\, marketing\, and reimbursement.  Scott is currently the Director of Market Access for BrainsWay where he leads the reimbursement efforts for Deep transcranial magnetic stimulation (Deep TMS) technology.  Prior to BrainsWay\, Scott was the National Director for payer policy and reimbursement for Medical Technology Partners\, Inc. (MTP)\, a well-known and respected medical device reimbursement consulting company.  Scott played an important role at MTP by leading payer coverage acceleration and market access tactics and strategies for a number of medical device companies over the past nine years including neurostimulation technologies.  Before joining MTP\, he held market access and sales professional roles at Olympus\, Cyberonics (now known as LivaNova)\, and at his first healthcare company\, Pfizer.  During Scott’s 14-year career at Pfizer\, he promoted their CNS therapeutic products for conditions including depression\, obsessive-compulsive disorder\, bipolar disorder\, anxiety disorders\, schizophrenia\, and Alzheimer’s disease.  Thus\, he is very acquainted with the TMS industry and the challenges our customers face in the mental health market.  Before his healthcare career\, Scott served as a captain in the United States Marine Corps for nine years and is a graduate of the University of South Carolina. \nAron Tendler\, MD \nDr. Tendler is board certified in general psychiatry\, obesity medicine and sleep medicine. He sees patients thirty hours a week\, and is engaged in clinical research and education on neuromodulation as the Chief Medical Officer for BrainsWay thirty hours a week.
URL:https://clinicaltmssociety.org/event/how-to-best-utilize-the-new-ctmss-recommended-ocd-coverage-policy/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/2021_March_Insurance_Webinar_Thumbnail_V2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201118
DTEND;VALUE=DATE:20201119
DTSTAMP:20260613T133709
CREATED:20201107T195259Z
LAST-MODIFIED:20241118T202658Z
UID:1500-1605657600-1605743999@clinicaltmssociety.org
SUMMARY:CTMSS Product Theater Webinar with MAGVENTURE
DESCRIPTION:CTMSS Product Theater Webinar - ON-DEMAND\n \nDate: Wednesday\, November 18\, 2020\nFormat: On-Demand \nThe Advantages of Robotic TMS in The Context of The COVID-19 Pandemic \nThe TMS-Cobot is the only FDA cleared robotic TMS solution for MagVenture TMS Therapy. MagVenture is proud to be partners with Axilum Robotics in offering a solution to significantly eliminate patient operator contact during routine TMS procedures. \nWhat are the general advantages of The TMS-Cobot? \n\nThe TMS-Cobot\, with its optical Tracking System\, controls the real-time position\, orientation and tilt of the TMS coil during the session. There is no need for the operator to adjust coil position during the session.\nAutomatically compensates for potential head motion during the TMS session and reduces the movement constraint of the patient.\nMaintains contact between the coil and head with its integrated contact sensor.\n\nLearning objectives \n\nIntroduction to Robotic TMS;\nTMS-Cobot implementation and how it works to reduce patient and operator interaction;\nDemonstration of the FDA cleared TMS-Cobot.\n\nFormat: LIVE \nFREE TO REGISTER! \n**Webinar log-in information will be sent out via email. \nDisclaimer: The content does not necessarily reflect the views and opinions of the Clinical TMS Society or its members and is solely determined by the sponsor. \n\nPresenters: \n\nMichel Berg\, MD\, CEO of Axilum Robotics \nDr. Berg is a medical doctor and a business school graduate\, he built his experience within the pharmaceutical and medical device industry before co-founding Axilum Robotics in 2011 with a team of experts in medical robotics. \n\nRustin Berlow\, MD \nDr. Berlow is a psychiatrist in a California private practice with years of TMS experience. He graduated from Columbia University College of Physicians and Surgeons medical school in 1990. After 23 years of psychopharmacology Dr. Berlow added procedural diagnosis & brain stimulation. Initial visit includes HRV\, GSR and EEG. Magnetic stim: rTMS\, TBS\, accelerated\, deep TMS. Electric stim: tDCS\, tACS\, Trigeminal and tVNS (Transcutaneous Vagus Nerve Stimulation). EEG-TMS - how to predict and personalize treatment). \n\n\n\nWhen\nNovember 18th\, 2020 from  5:00 PM to  6:00 PM
URL:https://clinicaltmssociety.org/event/ctmss-product-theater-webinar-with-magventure/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/MagVenture_Product_Theater_Event_Thumbnail.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200902
DTEND;VALUE=DATE:20200903
DTSTAMP:20260613T133709
CREATED:20241107T194804Z
LAST-MODIFIED:20241108T134118Z
UID:1495-1599004800-1599091199@clinicaltmssociety.org
SUMMARY:CTMSS Product Theater Webinar
DESCRIPTION:CTMSS Product Theater Webinar\n \nDate: Tuesday\, September 22\, 2020\nTime: 5:00 pm PDT / 7:00 pm CDT / 8:00 pm EDT \nStimGuide\, An Innovative Solution to Optimize TMS Treatments\nAdoption of 3D Navigation with EMG in the Clinical Practice Setting \nThis session will provide an overview of the workflow for the StimGuide 3D Navigation System and how it can be used in the clinical setting to improve: \n\nPrecise and consistent coil placement\nQuality control and consistency for both novice and expert TMS technicians\nSimplifying MT determination utilizing EMG option\n\nSession Objectives: Upon completion of the presentation\, the participant should have a clear understanding about how 3D navigation and EMG can be used in the clinical setting to optimize TMS treatments\, and how it differs from other navigation systems that require an MRI.  Specifically\, the following aspects will be covered: \n\nRegistration of treatment target(s) and how these can be recalled for subsequent treatment sessions to ensure reliable coil positioning for both novice and expert technicians.\nPositioning the coil in the pre-determined treatment target by aligning the 4 parameters (xy location\, contact\, tilt\, & rotation) within the specified tolerances\nUtilizing EMG to facilitate rMT Determination\nTracking and monitoring coil position in real-time to maintain consistent positioning during a treatment\nHow StimGuide can be used as a quality management tool for clinical sites that have multiple technicians and treaters\n\nFormat: LIVE \nFREE TO REGISTER! \nRegister online by Monday\, September 21\, 2020. \n**Webinar log-in information will be sent out via email the day prior on September 21\, 2020. \nDisclaimer: The content does not necessarily reflect the views and opinions of Clinical TMS Society or its members and is solely determined by the sponsor. \n\nPresenters: \n\nFoster\, Lance C\, MD \nDr. Lance Foster is a Child and Family Psychiatrist at Northwest Arkansas Psychiatry. He is Board Certified in General Psychiatry and also in Child and Adolescent Psychiatry by the American Board of Psychiatry and Neurology. He serves as an adjunct Associate Professor of Psychiatry at the University of Arkansas for Medical Sciences. Dr. Foster is a member of the Clinical TMS Society and provides TMS therapy for patients suffering from depression. Dr. Foster was the Chief Medical Officer and a staff psychiatrist at Ozark Guidance Center for 15 years. As a staff psychiatrist\, he provided psychiatric care for preschool through adult\, Therapeutic Day Treatment programs\, and the Child and Adolescent residential program. Dr. Foster is professionally affiliated with the American Psychiatric Association\, Arkansas Psychiatric Society\, American Academy of Child and Adolescent Psychiatry\, and the American College of Physician Executives. \n\nStaley\, Randall\, MD \nDr. Randall Staley joined Northwest Arkansas Psychiatry in 2018. Dr. Staley is board certified in Child and Adolescent Psychiatry and Adult Psychiatry by the American Board of Psychiatry and Neurology. He has practiced primarily with children and adolescents for more than 10 years\, working with ADHD and other issues in Northwest Arkansas. Dr. Staley is a member of the Clinical TMS Society and provides TMS therapy for patients suffering from depression. \n\n\n\nWhen\nSeptember 22nd\, 2020 from  5:00 PM to  6:00 PM
URL:https://clinicaltmssociety.org/event/1495/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/Magstim_Product_Theater_Event_Thumbnail_V2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200506
DTEND;VALUE=DATE:20200507
DTSTAMP:20260613T133709
CREATED:20241107T194539Z
LAST-MODIFIED:20241108T134210Z
UID:1491-1588723200-1588809599@clinicaltmssociety.org
SUMMARY:2020 Annual Member Meeting Webinar
DESCRIPTION:Please join the Society President\, Todd Hutton\, MD and Executive Director\, Ashleigh Servadio\, MSC\, for the Society’s Annual Member Meeting webinar on Wednesday\, May 6\, 2020 at 4:00 PM (PDT) / 7:00 PM (EDT). \nPresident\, Todd Hutton\, MD will provide a recap of the 2019-2020 year and we will also introduce the newly elected 2020-2021 Board of Directors. \nThis meeting is only for current CTMSS members.
URL:https://clinicaltmssociety.org/event/2020-annual-member-meeting-webinar/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/Annual_Member_Meeting_event_thumbnail.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191107
DTEND;VALUE=DATE:20191108
DTSTAMP:20260613T133709
CREATED:20241107T194414Z
LAST-MODIFIED:20241108T134715Z
UID:1487-1573084800-1573171199@clinicaltmssociety.org
SUMMARY:2019 Annual Member Meeting Webinar
DESCRIPTION:Please join the Society President\, Todd Hutton\, MD\, Immediate Past President\, Paul Croarkin\, DO and Executive Director\, Ashleigh Servadio\, MSC for the society’s annual members meeting webinar on Wednesday\, July 31\, 2019 at 5:30 PM (PDT). \nListen to updates on the society and learn more about the 2019-2020 Board of Directors. \nThis meeting is only for current CTMSS members. \nNo longer available
URL:https://clinicaltmssociety.org/event/2019-annual-member-meeting-webinar/
CATEGORIES:On-Demand Webinars
ATTACH;FMTTYPE=image/jpeg:https://clinicaltmssociety.org/wp-content/uploads/2024/11/Annual_Member_Meeting_event_thumbnail.jpg
END:VEVENT
END:VCALENDAR